Profund Advisors
CATX icon

Profund Advisors’s Perspective Therapeutics CATX Stock Holding History

Profund Advisors’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-56,714
Closed -$193K – 1123
2026
Q2 		$193K Buy
56,714
+15,147
+36% +$57.2K 0.01% 1101
2026
Q1 		$173K Buy
+41,567
New +$176K 0.01% 1047
2024
Q4 		– Sell
-20,261
Closed -$270K – 1119
2024
Q3 		$270K Buy
+20,261
New +$269K 0.01% 859

Other funds holding CATX

WealthPlan Investment Management
WealthPlan Investment Management Omaha, Nebraska $2.07B AUM 21.2% 1-Year Est. Return
Trueblood Wealth Management
Trueblood Wealth Management Lima, Ohio $284M AUM 20.17% 1-Year Est. Return
Taylor & Morgan Wealth Management
Taylor & Morgan Wealth Management Flint, Michigan $208M AUM 15.78% 1-Year Est. Return
Auctus Advisors
Auctus Advisors Charlotte, North Carolina $124M AUM 17.41% 1-Year Est. Return
Koa Wealth Management
Koa Wealth Management Encinitas, California $154M AUM 13.16% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return
Iowa State Bank
Iowa State Bank Urbandale, Iowa $592M AUM 21.15% 1-Year Est. Return
Provenance Wealth Advisors
Provenance Wealth Advisors Fort Lauderdale, Florida $1.69B AUM 11.53% 1-Year Est. Return
Wealth Effects
Wealth Effects Boston, Massachusetts $370M AUM 63.53% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return

Profund Advisors's CATX Position: Q3 2026 in Review

Profund Advisors sold out of Perspective Therapeutics (CATX) in Q3 2026, closing a stake of 56,714 shares — an estimated $193K sold.

Profund Advisors first reported a position in CATX in Q3 2024 and held it in 3 quarters. The position peaked at $270K in Q3 2024. 16 funds tracked by Wall St. Rank hold CATX as of Q3 2026.

  • Profund Advisors reported no remaining Perspective Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Profund Advisors sold 56,714 Perspective Therapeutics shares in Q3 2026, an estimated $193K.
  • Profund Advisors first reported a position in Perspective Therapeutics in Q3 2024 and held it in 3 quarters.
  • Profund Advisors's Perspective Therapeutics position peaked at $270K in Q3 2024.
  • 16 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q3 2026.

Based on Profund Advisors's 13F filing for Q3 2026, filed 29 Oct 2026.